Patient s potential idiosyncratic toxicities. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Liver Cells, Cultured Cell Line, Tumor Kidney Cell Line Bone Marrow Neurons Lung Tumor Cells, Cultured Hepatocytes Mitochondria Urogenital System

Organisms12

Rats, Sprague-Dawley Rats, Inbred F344 Daphnia Mice, Inbred C57BL Bacillus thuringiensis Rats, Wistar Mice, Inbred BALB C Artemia Larva Mice, Nude Rabbits Mice, Inbred ICR

Diseases45

Neoplasms Leukopenia Drug-Related Side Effects and Adverse Reactions Radiation Injuries Drug-Induced Liver Injury Neutropenia Hematologic Diseases Lung Neoplasms Thrombocytopenia Nausea Neurotoxicity Syndromes Body Weight Neoplasm Metastasis Plant Poisoning Neoplasm Recurrence, Local Stomatitis Breast Neoplasms Adenocarcinoma Abnormalities, Drug-Induced Vomiting Carcinoma, Non-Small-Cell Lung Drug Eruptions Disease Models, Animal Gastrointestinal Diseases Drug Overdose Poisoning Mucositis Colorectal Neoplasms Disease Progression Exanthema Head and Neck Neoplasms Ovarian Neoplasms Prostatic Neoplasms Radiodermatitis Brain Neoplasms Male Urogenital Diseases Lymphoma, Non-Hodgkin Kidney Diseases Necrosis Melanoma Alopecia Diarrhea Kidney Neoplasms Liver Neoplasms Carcinoma, Squamous Cell

Chemicals and Drugs96

Antineoplastic Agents Cisplatin Fluorouracil Doxorubicin Deoxycytidine Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Paclitaxel Antidotes Camptothecin Cyclophosphamide Carboplatin Taxoids Teratogens Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Etoposide Environmental Pollutants Glutathione Insecticides Vinblastine Methotrexate Antineoplastic Agents, Alkylating Plant Extracts Vincristine Antibiotics, Antineoplastic Antibodies, Monoclonal Acetaminophen Prodrugs Ifosfamide Cadmium Methylmercury Compounds Dacarbazine Aluminum Cytochrome P-450 CYP2E1 Neurotoxins Dihydrouracil Dehydrogenase (NADP)Drug Carriers Bacterial Toxins Amyloid beta-Peptides Recombinant Proteins Antioxidants Antibodies, Monoclonal, Humanized Bleomycin Reactive Oxygen Species L-Lactate Dehydrogenase Topotecan Amifostine Melphalan Herbicides Immunotoxins Xenobiotics Endotoxins Cytarabine Tetrachlorodibenzodioxin Enzyme Inhibitors Liposomes Toxins, Biological Epirubicin Carmustine Drug Combinations Prednisone Organophosphorus Compounds Quinazolines Thiazoles Superoxide Dismutase Ethylene Glycols Paraquat Yttrium Radioisotopes Selenium Compounds Hazardous Substances Niacinamide Radiation-Sensitizing Agents Mitomycin Peptides Metals, Heavy Mercury Lead Neuroprotective Agents Polyethylene Glycols Carcinogens Mycotoxins Mitoxantrone Copper Phenylurea Compounds Pyridines Benzenesulfonates Amphotericin B Tegafur Guanine Marine Toxins Buthionine Sulfoximine Alanine Transaminase Triazines Granulocyte Colony-Stimulating Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment60

Toxicity Tests Toxicity Tests, Acute Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Treatment Outcome Infusions, Intravenous No-Observed-Adverse-Effect Level Maximum Tolerated Dose Administration, Oral Combined Modality Therapy Drug Evaluation Toxicity Tests, Subchronic Survival Analysis Disease-Free Survival Radiotherapy Dosage Drug Evaluation, Preclinical Survival Rate Animal Testing Alternatives Radiotherapy Organ Size Toxicity Tests, Subacute Dose Fractionation Body Weight Radiotherapy, Conformal Area Under Curve Neoplasm Staging Remission Induction Injections, Intravenous Salvage Therapy Radioimmunotherapy Clinical Trials, Phase I as Topic Drug Carriers Radiotherapy, Intensity-Modulated Disease Models, Animal Follow-Up Studies Drug Delivery Systems Drug Overdose Feasibility Studies Chemotherapy, Adjuvant Mutagenicity Tests Retrospective Studies Hematologic Tests Injections, Intraperitoneal Clinical Trials as Topic Metabolic Clearance Rate Chemoradiotherapy Dose-Response Relationship, Radiation Drug Therapy, Combination Blood Cell Count Prospective Studies Carcinogenicity Tests Models, Biological Biological Assay Injections, Subcutaneous Inhibitory Concentration 50 Pilot Projects Chromatography, High Pressure Liquid Xenograft Model Antitumor Assays

Phenomena and Processes33

Dose-Response Relationship, Drug Lethal Dose 50 No-Observed-Adverse-Effect Level Cell Survival Maximum Tolerated Dose Time Factors Drug Interactions Organ Size Body Weight Area Under Curve Oxidative Stress Apoptosis Tissue Distribution Drug Synergism Cell Death Biotransformation Metabolic Detoxication, Drug Particle Size Drug Resistance, Neoplasm Mutation Molecular Structure Structure-Activity Relationship Metabolic Clearance Rate Dose-Response Relationship, Radiation Blood Cell Count Half-Life Cytoprotection Necrosis Larva Inhibitory Concentration 50 Genetic Vectors Lipid Peroxidation Oxidation-Reduction

Disciplines and Occupations4

Toxicology Toxicogenetics Ecotoxicology Pharmacogenetics

Technology, Industry, Agriculture4

Nanoparticles Metal Nanoparticles Liposomes Polyethylene Glycols

Information Science3

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care17

Treatment Outcome Radiation Injuries Survival Analysis Disease-Free Survival Survival Rate Area Under Curve Clinical Trials, Phase I as Topic Follow-Up Studies Feasibility Studies Retrospective Studies Clinical Trials as Topic Dose-Response Relationship, Radiation Prospective Studies Societies, Scientific Pilot Projects Inhalation Exposure Pest Control, Biological

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Toxicity Tests Toxicity Tests, Acute Dose-Response Relationship, Drug Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Antineoplastic Agents Treatment Outcome Cisplatin Infusions, Intravenous No-Observed-Adverse-Effect Level Fluorouracil Cell Survival Maximum Tolerated Dose Neoplasms Administration, Oral Doxorubicin Combined Modality Therapy Time Factors Toxicology Deoxycytidine Drug Evaluation Leukopenia Antineoplastic Agents, Phytogenic Drug-Related Side Effects and Adverse Reactions Antimetabolites, Antineoplastic Radiation Injuries Paclitaxel Drug-Induced Liver Injury Liver Neutropenia Toxicity Tests, Subchronic Antidotes Survival Analysis Camptothecin Cyclophosphamide Disease-Free Survival Radiotherapy Dosage Carboplatin Hematologic Diseases Lung Neoplasms Taxoids Teratogens Drug Evaluation, Preclinical Survival Rate Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Thrombocytopenia Etoposide Animal Testing Alternatives Environmental Pollutants Glutathione Rats, Sprague-Dawley Insecticides Vinblastine Methotrexate Radiotherapy Antineoplastic Agents, Alkylating Drug Interactions Organ Size Cells, Cultured Nausea Toxicity Tests, Subacute Neurotoxicity Syndromes Plant Extracts Dose Fractionation Vincristine Body Weight Antibiotics, Antineoplastic Nanoparticles Radiotherapy, Conformal Antibodies, Monoclonal Area Under Curve Cell Line, Tumor Oxidative Stress Neoplasm Staging Kidney Neoplasm Metastasis Acetaminophen Plant Poisoning Apoptosis Tissue Distribution Drug Synergism Remission Induction Cell Line Neoplasm Recurrence, Local Cell Death Injections, Intravenous Salvage Therapy Stomatitis Radioimmunotherapy Prodrugs Rats, Inbred F344 Breast Neoplasms Ifosfamide Cadmium Methylmercury Compounds Biotransformation

No FAQ available that match "patient s potential idiosyncratic toxicities"